Stock Research: Bachem

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

Bachem

SWX:BANB CH1176493729
37
  • Value
    94
  • Growth
    21
  • Safety
    Safety
    51
  • Combined
    67
  • Sentiment
    18
  • 360° View
    360° View
    37
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Bachem Holding AG is a biochemical company providing services to the pharmaceutical and biotechnology industries. It focuses on the process development and manufacturing of peptides and organic molecules as active pharmaceutical ingredients (APIs). It operates under the Bachem and Clinalfa brands. The company operates in Switzerland and the United States. In the last fiscal year, the company had a market cap of $5,320 million, profits of $201 million, and revenue of $667 million, with 2207 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 37 (better than 37% compared with alternatives), overall professional sentiment and financial characteristics for the stock Bachem are below the industry average. The 360° View is based on consolidating four consolidated indicators, with half the metrics below and half above average for Bachem. The consolidated Value Rank has an attractive rank of 51, which means that the share price of Bachem is on the lower side compared with the typical size in indicators such as revenues, profits, and invested capital. This means the stock price is lower than for 51% of alternative stocks in the same industry. The company is also safely financed with a Safety rank of 94. But the professional market sentiment is below average compared with other stock investment alternatives with a Sentiment Rank of 18. Professional investors are more confident in 82% other stocks. The consolidated Growth Rank also has a low rank of 21, which means that the company is below average in terms of growth momentum when looking at financial metrics such as revenue, profit, invested capital growth, and stock returns. 79 of its competitors have better growth. ...read more

more
Index
SDG 12
SDG 3
SDG 4
SDG 8
SPI
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 13-Nov-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
51 47 45 35
Growth
21 24 83 99
Safety
Safety
94 100 98 90
Sentiment
18 75 13 12
360° View
360° View
37 85 82 73
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
11 5 1 17
Opinions Change
43 62 75 26
Pro Holdings
n/a 80 53 72
Market Pulse
39 87 4 38
Sentiment
18 75 13 12
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
51 47 45 35
Growth
21 24 83 99
Safety Safety
94 100 98 90
Combined
67 78 100 100
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
45 33 30 11
Price vs. Earnings (P/E)
17 13 17 28
Price vs. Book (P/B)
51 40 37 13
Dividend Yield
65 72 63 61
Value
51 47 45 35
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
89 75 80 75
Profit Growth
25 42 56 78
Capital Growth
21 11 95 86
Stock Returns
15 37 35 95
Growth
21 24 83 99
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
94 95 96 49
Refinancing
55 60 59 96
Liquidity
98 100 100 96
Safety Safety
94 100 98 90

Similar Stocks

Discover high‑ranked alternatives to Bachem and broaden your portfolio horizons.

Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt.

BUSE:RICHTER
Country: Hungary
Industry: Pharmaceuticals
Size: Medium
Full Stock Analysis

Ipsen

ENXTPA:IPN
Country: France
Industry: Pharmaceuticals
Size: Large
Full Stock Analysis

ALSO

SWX:ALSN
Country: Switzerland
Industry: Technology Distributors
Size: Medium
Full Stock Analysis

SoftwareONE Holding

SWX:SWON
Country: Switzerland
Industry: Technology Distributors
Size: Medium
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.